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Abstract
Background: Leiomyoma is the most common benign tumor of the esophagus. Surgical enucleation is indicated
in case of symptoms or an unclear diagnosis, and open thoracotomy has long been the standard approach for this
procedure. However, enucleation through video assisted thoracoscopic surgery (VATS) has been developed as a
preferred approach for most lesions in recent years.
Method: Herein we report our twelve patients (seven men and five women, with median age of 42 years) from
2001 to 2009, who underwent enucleation through VATS for esophageal leiomyomas, with a size from 1 to 8 cm
in diameter (median: 5), and at different locations, from the thoracic outlet to near the diaphragmatic level of the
thoracic esophagus. Intraoperative fiberoptic esophagoscopy was performed in two patients for localization by
illumination. A right-sided approach was performed in eight cases (upper two thirds of esophagus) and the left-
sided in another four cases (lower third of esophagus).
Result: The median operative time was 95 minutes (70 to 230 minutes). Four of them required small utility
incisions (4-6 cm) for better exploration and manipulation. There were no major complications, such as death or
empyema due to leaks from mucosal tears, and the presenting symptoms were improved during the follow-up
period, from 12 to 98 months.
Conclusion: VATS can be considered as an initial approach for most patients with esophageal leiomyomas, even
large in size, irregular in shape, or at unfavorable location. It is a safe, minimally invasive, and effective treatment.
However, conversion to open thoracotomy should be required for the sake of clinical or technical concern.
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Background
Benign tumors of the esophagus are uncommon, and
the incidence varies from 0.005% to 5.1% in autopsy
cases; and from less than 1% to 10% in all esophageal
neoplasms [1-3]. Leiomyomas constitute 70-80% of all
benign esophageal neoplasms [1,3-5]. Other benign eso-
phageal tumors such as gastrointestinal stromal tumors,
granular cell tumors or schwannomas are extremely
rare. Esophageal leiomyomas are usually found in
patients between 20 and 50 years of age, with an about
twofold more male predominance commonly occurring
in the lower two-thirds of esophagus [4,5]. Most of
these patients are asymptomatic. Dysphagia is the most
common symptom, followed by chest tightness and
pain. The treatment strategy for esophageal leiomyomas
is to continue follow-up dealing with smaller tumors
and to do a surgical resection of larger or symptomatic
tumors. The traditional open thoracotomy for enuclea-
tion of this tumor has been gradually replaced by mini-
mally invasive thoracoscopic or laparoscopic approaches
since 1992 [1,3,6-12]. Video assisted thoracoscopic sur-
gery (VATS) is selected for patients with leiomyomas
located in the upper two-thirds of thoracic esophagus.
However, either VATS or laparoscopic approaches have
been reported to be used in patients with leiomyomas in
the lower thirds of the esophagus [9,10]. Herein we pre-
sent our experiences with patients having esophageal
leiomyomas, who underwent surgical enucleation suc-
cessfully by VATS. * Correspondence: shengmou@ms.skh.org.tw
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From 2001 to 2009, a total of twelve patients with
benign esophageal tumors were operated on through
video-assisted thoracoscopic surgery (VATS) at our hos-
pital. There were seven males and five females, with
ages ranging from 26 to 65 years (median: 42 years).
Surgical indications for enucleation were: symptoms of
dysphagia, odynophagia, foreign body sensation on swal-
lowing, and chest tightness; or the presence of a large
sized tumor (≧ 4 cm). All of these above patients under-
went detailed assessment, including a barium or urograf-
fin swallowed esophagogram, an upper esophago-gastro-
duodenal endoscopy, and computerized tomography
(CT) of the chest (Figure 1 and 2). Six patients (50% of
them) underwent endoscopic ultrasound (EUS) exami-
nations. Endoscopic biopsies of the leiomyoma were
taken on five patients (42% of them) because of the pos-
sibility that malignancy could not be excluded.
The minimal invasive surgical approaches for these
patients included right VATS for tumors of the upper
two-thirds of the esophagus, and left VATS for tumors
of the lower third of the esophagus. Intraoperative endo-
scopy allowed for precise localization of the lesion for
transillumination in two patients that had small lesions
(1 cm and 1.5 cm in size). In one of our patients, Belsey
Mark-IV, an anti-reflux procedure was added because
the tumor was large (4 cm in size) and located near the
gastro-intestinal junction.
The VATS procedure is done under general anesthesia
with double lumen intubation. The patient is placed in a
right or left lateral decubitus position at about a 15°
frontal incline. Three to four 10 to 12 mm cameras or
working ports are placed over the chest wall, depending
upon the location of the mass, and sometimes a working
incision (without use of the spreader) is made about 3
to 4 cm in one of the ports, to facilitate the instruments
manipulation. After the lesion is visualized by thoraco-
scopy or transilluminated by endoscopy, the mediastinal
pleura over the tumor is incised longitudinally by an
endoscopic hook electrocauterizer. Then the esophagus
is circumferentially mobilized to facilitate exposure, and
to avoid injuring the vagus nerve during this procedure.
The mass is exposed after the overlying muscle is split
longitudinally. The retracting suture is placed over the
mass and then you must meticulously dissect the plane
between the mass and the submucosal layer. The integ-
rity of the mucosa must then be checked by observing if
there is any bubble appearance in the water-submerged
esophagus, after insufflating air through the nasogastric
tube. The muscle layer is re-approximated and a 28 or
32 Fr chest tube is place through one of the ports (Fig-
ure 3 and 4).
Figure 1 A. Esophagogram of Case 10. Reveals typical findings of intramural tumor (T) near the esophago-gastric junction: smooth surface,
clear-cut margins, and sharp angles at upper and lower ends of the tumor. E: esophagus. B. Endoscopic view of the esophageal leiomyoma (T).
(Case 10).
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The operative time ranged from 70 to 230 minutes
(median, 95 minutes). All of these twelve patients had
single lesion tumors and tumor size was in the range of
1 to 8 cm (median, 5 cm). The location, size and shape
of the tumors are listed in Table 1. Eight of our patients
with tumors in the upper two-thirds of esophagus
underwent a right-sided VATS approach, and four of
them with lower third esophageal tumors underwent a
left sided approach. The operative course was uneventful
for all of them. Postoperatively, a nasogastric tube was
kept in place for three to seven days, until no evidence
of leakage was found on the esophagrams that were per-
formed on all of our patients postoperatively. A liquid
diet for 24 hours was followed by a soft diet, given after
the above assessment proved there was no leakage. The
chest tube was removed in a range of between the 5
th to
the 9
th postoperative day (median: 7 days). All twelve
patients could have been discharged on the same day,
b u tt w oo ft h et w e l v ee l e c t e dt os t a yi nt h eh o s p i t a lf o r
one to two more days because of socio-cultural factors.
No major complications, such as esophageal leakage,
wound infection, or pneumonia, were found postopera-
tively in these patients. Histopathology confirmed
benign esophageal leiomyoma with the appearance of
uniform spindle cells, without abnormal mitotic figures.
The immunohistochemical staining was positive for des-
min and SMA, and negative for CD117 or CD34. All
the patients were generally well and without dysphagia,
gastro-esophageal reflux, tumor recurrence, or other
related events during the twelve-months to eight-years
of follow-up. At least 6 times of follow-up at the out-
patient clinic for these patients were undertaken. Eso-
phagogram, panendoscopy, or chest CT was used every
three months postoperatively for these patients. Inter-
view by telephone call was used for patients who were
Figure 2 Computed tomography, cross section (A). Reveals the esophageal lumen being compressed forwards by horse-shoe shaped (T1 and
T2) leiomyoma. Coronal section (B). Reveals this tumor (T) compressing the esophagus (E) and adjacent structures of mediastinum. (Case 9).
Figure 3 Intraoperative view of the right thoracic cavity with
an esophageal leiomyoma (T) close to the azygos vein (Az)
and compressing the esophagus (E) anteriorly. (Case 11).
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tions in the clinic.
Discussion
More than 90% of esophageal tumors are malignant.
The leiomyoma is the most common benign esophageal
tumor seen, and also very rarely seen. Other benign
tumors of esophagus, such as lipoma or neurilemmoma,
were extremely rare [12]. The reason for its occurrence
remains unclear. Most leiomyomas of the esophagus
arise from the muscularis propria, with some others
from the muscularis mucosa [3]. Small tumors are
usually asymptomatic, and are mostly round or oval-
shaped. Larger tumors are more likely to be sympto-
matic, and will become lobular or horseshoe shaped,
when surrounding the esophagus circumferentially in
endoscopic or CT findings [4,13,14]. The most common
location of the esophageal leiomyoma varied in different
series, but was in the middle or lower third of the eso-
phagus [1,4,13,14]. Esophagogastroscopy combined with
endoscopic ultrasonographic evaluation of the tumor is
mandatory in order to exclude cancer of esophagus
from the differential diagnosis. Leiomyoma’st y p i c a l
appearance is of homogeneous and hypoechoic lesion
with clear margin [9]. A contrast enhanced CT scan of
the chest can demonstrate the extent of extraluminal
involvement of the mass and exclude the possibility of
malignancy. Endoscopic biopsy of submucosal or intra-
m u r a lt u m o r so ft h ee s o p h a g u si sn o tr e c o m m e n d e d
because the subsequent mucosal defects or scarring will
hamper surgical dissection and enucleation of the tumor
[1]. However, sometimes this procedure is necessary to
Figure 4 A. Intraoperative view of the right thoracic cavity with a horse-shoe shape leiomyoma (T1 and T2) near the azygos vein (Az)
removed from the esophagus (E). and B. surgical specimen of horse-shoe shape leiomyoma. (Case 11).
Table 1 Clinical data of 12 patients undergoing VATS enucleation of esophageal leiomyomas
Patient Sex Age
years
Special procedure Tumor
location
Size
(cm)
Shape VATS
approach
OpTime minutes Post op
Chest tube drainage duration (days)
1 F 43 Bx. middle 4 Ov Rt 200 7
2 M 32 Bx. middle 5 Hs Rt 85 5
3 M 47 Bx. upper 3 Ov Rt 100 7
4 F 41 Bx. middle 4.5 Ov Rt 150 5
5 M 26 EUS. lower 2 Ro Lt 85 5
6 F 50 Bx. upper 3 Ov Rt 90 5
7 M 30 EUS. middle 4 Ov Rt 120 6
8 M 53 EUS. lower 2 Ro Lt 85 6
9 M 65 EUS. middle 8 Hs Rt 230 9
10 F 27 Op-EGD lower 1.5 Ro Lt 75 6
11 F 34 Bx. middle 7 Hs Rt 210 7
12 M 49 EUS. Op-EGD lower 1 Ro Lt 70 6
Op-EGD: intra-operative esophagogastroduodenoscopy, EUS: endoscopic ultrasound.
Bx: endoscopic biopsy. Ov: ovoid, Ro: round, Hs: horse-shoe.
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epithelial malignancies such as leiomyosarcoma, gastro-
intestinal stromal tumors (GISTs) or carcinoma [15].
Five of our patients (42%) underwent this procedure
pre-operatively. However, from our experience with pre-
vious studies a reliable diagnosis could not be obtained
by this procedure. Our experience shows that the risk of
mucosal perforation is higher if the biopsy was taken in
deeper layers of the esophagus [1,3]. Differential diagno-
sis of benign or malignant esophageal mesenchymal
tumors should be made by histopathological examina-
tion with immunohistochemical staining [16]. Both
epitheloid and spindle cells can be seen in GISTs but
only spindle cells can be seen in leiomyomas. There are
about 20% of GISTs and 5% of leiomyomas diagnosed
as malignant. Surgical therapy is usually indicated for
patients with larger (≧ 5 cm) or symptomatic tumors
[4]. However, we think that it can be useful in selected
patients with smaller asymptomatic tumors because of
its progressive growth in its natural course. There is
also a possibility of malignancy and an indication for
related minimally invasive surgery or endoscopic proce-
dures [17].
The first successful resection and enucleation of a
benign esophageal tumor was reported in 1932 and
1933 [18,19]. Surgical enucleations of esophageal leio-
myomas by video assisted thoracoscopic surgery (VATS)
have also been reported since 1992, and have contribu-
ted to a growing interest in use of this approach in
recent years [6,20]. This minimally invasive approach
has avoided morbidity associated with open thoracot-
omy, and such complications as wound pain and pul-
monary atelectasis [21,22]. VATS is the preferred
minimally invasive approach for enucleation of upper
two-third leiomyomas of the esophagus, and laparo-
scopic approach can be an alternative to VATS for
tumors of the lower third of esophagus [10,23]. Open
surgical enucleation or even segmental esophagectomy
is still required in some patients with giant esophageal
leiomyomas [11,24]. There are some technical points to
be considered during enucleation of the esophageal leio-
myoma through VATS [1,21]. First, the operation
should be postponed for at least two weeks after the
patient undergoes endoscopic biopsy, to allow healing of
the esophageal mucosa. Second, endoscopy can be used
intra-operatively for localization of small tumors or for
checking the mucosal integrity after enucleation. Third,
doing a myotomy in the correct direction and right
level, you must place traction sutures in the tumor so as
to facilitate subsequent enucleation. An interrupted
s u t u r er e p a i rc a nb em a d et h r o u g hV A T Si fas m a l l
mucosa tear is noted. Fourth, no matter how large the
esophageal leiomyoma is, enulceation should be done
first. Esophagectomy should only be considered if the
attempt at nucleation fails. Fifth, the approximation of
the esophageal muscle after enucleation, should be per-
formed to avoid possible motility disorders or pseudodi-
verticulum formation.
The choice of minimally invasive approaches for leio-
myomas in the upper two- thirds of the esophagus are
undoubtedly through VATS, but either laparoscopic
[3,9,10] or VATS [1,23] approaches can be used for
those tumors in the lower third of the esophagus.
Though leiomyomas in the lower third of the esophago-
gastric (EG) junction of the esophagus are not com-
monly accompanied by acid regurgitation or other moti-
lity disorders in some other series [3,9], only one of our
patients was noted to have symptoms of heart burn.
Procedures for motility or reflux disorders of the eso-
phagus can also be performed through VATS [17].
Furthermore, less disturbance to the EG junction with
lower prevalence of postoperative reflux disorders of the
esophagus were found in patients undergoing VATS
procedures during our experiences and prior reported
series [1,23]. Thus we used the VATS approach for all
leiomyomas located from the thoracic outlet to the EG
junction of the esophagus.
Choosing to use the minimally invasive or open
approach to treat esophageal leiomyomas depends on
their size, shape and location. We have routinely tried
the minimally invasive approach first, and would then
convert to the open approach when there was a safety
concern or technical limitation [7]. We have dealt with
some cases of large or multiple leiomyomas of the eso-
phagus prior to 2001 that required conversion to open
thoracotomy. During the recent eight years we have suc-
cessfully performed minimally invasive procedures
through working ports or through small utility incisions
(without spreader). The choice of enucleation or esopha-
geal resection of esophageal leiomyomas also depends
on their size, shape and location. There are no formal
criteria for the selection of open or VATS approaches.
From our experiences the esophageal leiomyoma of any
size, shape or location can be tried to resect it through
VATS at first. Conversion to open procedure should be
considered in case of technical problems or limitations.
We think that esophagectomy should only be considered
when tumors fail to be enucleated [11,24]. Recently, the
development of robot assisted esophagectomy through
VATS, avoiding open thoracotomy, can be used for the
treatment of giant leiomyomas of esophagus [25].
Our experiences in VATS treatment for esophageal
leiomyomas have revealed satisfactory results with
symptomatic relief, the least wound pain, and excellent
wound cosmetics; and no major early or late complica-
tions have been found. VATS resections were feasible in
our series, with some tumors challenging us to use
minimally invasive techniques, when tumors were large
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phageal recess area. The median hospital length of stay
in our series is longer than other series because the cost
of the hospital stay in Taiwan is less expensive than in
other countries, and we do not want to see complica-
tions resulting from too early oral feedings. We believe
that all of our patients can take food orally about one to
two days post-operatively.
Conclusion
In conclusion, the resection of an esophageal leiomyoma
at any location of the thoracic esophagus can be tried
first through a VATS approach. Patients undergoing this
minimally invasive procedure, according to our prior
experiences and from literature, can benefit from limited
operative trauma, less postoperative pain, more rapid
recovery, shorter hospital stay and better wound cos-
metics. Pre-operative endoscopic biopsy should be
avoided unless a malignancy or mucosal lesion is sus-
pected. Enucleation of a lower third esophageal leio-
myoma through VATS procedure can result in less
disturbance to the EG junction and related complica-
tions. Esophagectomy for a benign tumor of esophagus
is not recommended unless enucleation fails to remove
the tumor.
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